Found: 15
Select item for more details and to access through your institution.
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22872-z
- By:
- Publication type:
- Article
United States Family Medicine research collaborations associated with higher citation and funding rates.
- Published in:
- Journal of Primary Health Care, 2021, v. 13, n. 3, p. 238, doi. 10.1071/HC20136
- By:
- Publication type:
- Article
Chronic Opioid Prescribing in Primary Care: Factors and Perspectives.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Distinct Translation Initiation Mechanism Generates Cryptic Peptides for Immune Surveillance.
- Published in:
- PLoS ONE, 2008, v. 3, n. 10, p. 1, doi. 10.1371/journal.pone.0003460
- By:
- Publication type:
- Article
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01655-0
- By:
- Publication type:
- Article
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Dual targeting of PI3K and BCL-2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 10, p. 3068, doi. 10.1111/jcmm.17297
- By:
- Publication type:
- Article
Me and Research, It's Complicated Reflections From an FMAHealth Fellow.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Supporting Family Medicine Research Capacity: The Critical Role and Current Contributions of US Family Medicine Organizations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Scholarly Output of Faculty in Family Medicine Departments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 11, p. 1, doi. 10.1038/s41419-023-06233-w
- By:
- Publication type:
- Article
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, p. 1, doi. 10.1186/s40164-024-00484-9
- By:
- Publication type:
- Article
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01257-9
- By:
- Publication type:
- Article
The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter